Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on February 28, 2026

Feb. 28, 2026

Accurate Subtyping of Attention Deficit Disorder Linked to Improved Treatment Outcomes

EIN Presswire

Feb. 28, 2026

Homewatch CareGivers of Huntington Newport Beach Demonstrates Leadership in Senior Home Care Services

EIN Presswire

16 hours ago

Bank Kuasa CUKTECH 25SE Melancarkan Debut Mantap di Malaysia, Mewujudkan Penanda Aras Baharu untuk Pengecasan Pantas Berkapasiti Tinggi

GlobeNewswire

16 hours ago

CUKTECH 25SE Power Bank Makes Its Powerful Debut in Malaysia, Setting a New Benchmark for High-Capacity Fast Charging

GlobeNewswire

17 hours ago

Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services

GlobeNewswire

Feb. 28, 2026

Sugar Harmony Drops Claims Evaluated: 2026 Report on SugarHarmony Liquid Formula Ingredients, Pricing, and What Consumers Should Verify Before Purchasing

GlobeNewswire

Feb. 28, 2026

Zealthy Hydroquinone 2026: Compounded Prescription Details, Online Dermatology Consultation Pricing, and What Consumers Should Verify Before Starting Treatment

GlobeNewswire

Feb. 28, 2026

Rising Mental Health Challenges in Pro Football Expose Urgent Need for Support

GlobeNewswire

Feb. 28, 2026

Zealthy ED Platform in 2026 (Including Hardies Sublingual Formulations): Telehealth ED Treatment Options, Compounded Medication Pricing, and What Consumers Should Verify Before Starting

GlobeNewswire

Feb. 28, 2026

BreezeMeds GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Pricing (From $199), FDA Regulatory Status Examined

GlobeNewswire

Feb. 28, 2026

ReduBurn Thermogenic Resistance Claims Evaluated: Latest Report on Ingredients, Pricing, Refund Terms, and What Consumers Should Verify Before Buying

GlobeNewswire